We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. CorMedix Inc. (NASDAQ:CRMD) announced that its board approved a share repurchase program authorizing up to $75 million in common stock buybacks, with the program set to remain in place through December 31, 2027. The company indicated the decision reflects confidence in its balance sheet strength, operating performance, and expected future cash flow generation, while maintaining flexibility to continue investing in internal ...